PAXIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.578800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.739800E-01
Normal-vs-Stage2
6.931000E-01
Normal-vs-Stage3
2.524000E-02
Normal-vs-Stage4
9.214600E-01
Stage1-vs-Stage2
5.500200E-01
Stage1-vs-Stage3
2.556400E-02
Stage1-vs-Stage4
9.142600E-01
Stage2-vs-Stage3
4.538000E-02
Stage2-vs-Stage4
5.175800E-01
Stage3-vs-Stage4
1.611190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.640000E-01
Normal-vs-AfricanAmerican
7.983800E-01
Normal-vs-Asian
5.851600E-01
Caucasian-vs-AfricanAmerican
8.756200E-01
Caucasian-vs-Asian
5.025800E-01
AfricanAmerican-vs-Asian
6.750200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.803000E-01
Normal-vs-Female
7.525800E-01
Male-vs-Female
4.365600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.635000E-01
Normal-vs-Age(41-60Yrs)
8.690600E-01
Normal-vs-Age(61-80Yrs)
5.477600E-01
Normal-vs-Age(81-100Yrs)
7.934800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.513600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.992600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.613200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.208190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.092600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.588400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.421400E-01
Normal-vs-Daily Drinker
4.101600E-01
Normal-vs-Weekly Drinker
8.596800E-01
Normal-vs-Occasional Drinker
4.485200E-01
Normal-vs-Social Drinker
9.791000E-01
Non Drinker-vs-Daily Drinker
5.916800E-01
Non Drinker-vs-Weekly Drinker
2.786800E-01
Non Drinker-vs-Occasional Drinker
9.861200E-01
Non Drinker-vs-Social Drinker
1.995630E-01
Daily Drinker-vs-Weekly Drinker
1.794780E-01
Daily Drinker-vs-Occasional Drinker
5.895600E-01
Daily Drinker-vs-Social Drinker
9.219500E-02
Weekly Drinker-vs-Occasional Drinker
2.806200E-01
Weekly Drinker-vs-Social Drinker
7.306000E-01
Occasional Drinker-vs-Social Drinker
1.570990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.259400E-01
Normal-vs-Grade 2
8.582200E-01
Normal-vs-Grade 3
8.924600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.355200E-01
Grade 1-vs-Grade 3
1.184200E-01
Grade 1-vs-Grade 4
8.259400E-01
Grade 2-vs-Grade 3
2.514600E-01
Grade 2-vs-Grade 4
8.582200E-01
Grade 3-vs-Grade 4
8.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.687000E-01
Normal-vs-NonDiabetic
6.545600E-01
Diabetic-vs-NonDiabetic
2.686800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.281200E-01
Normal-vs-NoPancreatitis
6.154800E-01
Pancreatitis-vs-NoPancreatitis
8.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.819800E-01
Normal-vs-N1
6.822000E-01
N0-vs-N1
9.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.071600E-01
Normal-vs-TP53-NonMutant
9.268800E-01
TP53-Mutant-vs-TP53-NonMutant
9.328600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
